David Clayton

David Clayton has a diverse range of work experience in the field of biotechnology and microbiology. David began their career as a Biochemistry Student at Queen Mary University of London, where they gained knowledge in biochemical processes and their applications in biotechnology and medicine. During their time there, they conducted a research project focused on gene regulation in cyanobacteria, utilizing various molecular biology and microbiology techniques.

After completing their studies, David worked as a Microbiologist at Stansted Laboratories Ltd for over a year. In this role, they gained experience in microbiological testing and analysis. David then joined Thermo Fisher Scientific as a Stability Microbiologist, where they were responsible for testing culture media and various IVDs for product stability and shelf-life.

David later joined Tropic Biosciences as a Laboratory Technician in the GEIGS Team. In this role, they provided technical support for the development and implementation of Genome Edited Induced Gene silencing (GEIGS) technology in tropical crops. Their responsibilities included cloning GEIGS plasmid constructs, transforming and maintaining plants with GEIGS constructs, and evaluating them for transgenic events.

David's next position was at OXGENE as an Associate Scientist, where they worked for a year. Unfortunately, the specifics of their role are not provided.

Most recently, David joined Epoch Biodesign as a Laboratory Technician. The details of their responsibilities and the duration of their employment are not mentioned.

Overall, David's work experience highlights their expertise in molecular biology, microbiology, and biotechnology, with a specific focus on genetic editing and gene regulation research.

David Clayton completed their A Levels from St. Gregory's Catholic Science College between 2014 and 2016. After that, they attended Queen Mary University of London from 2016 to 2019, where they obtained a Bachelor of Science degree in Biochemistry.